EUVIMEDEUVIMED entdecken
Crossref

Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer

Rinki Verma, Md Zeyaullah, Virendra Singh, Preeti Suman Saxena, Biplob Koch, Manoj Kumar iD

ACS Biomaterials Science & Engineering · 2025

DOI: 10.1021/acsbiomaterials.4c02390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Rinki Verma und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, IIT (BHU), Varanasi 221005, India. Hauptthemen laut MEDLINE: Methotrexate, Triple Negative Breast Neoplasms, Chitosan, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, fluorescent calcium carbonate nanoclusters encapsulated with methotrexate (Mtx) and surface functionalized with chitosan (25 nm) (@Calmat) have been developed for the imaging and treatment of triple-negative breast cancer (TNBC). These biocompatible, pH-sensitive nanoparticles demonstrate significant potential for targeted therapy and diagnostic applications. The efficacy of nanoparticles (NPs) was evaluated in MDA-MB-231 TNBC cell lines. The enhanced permeability and retention effect facilitated the accumulation of NPs, in tumor-bearing rats, as confirmed by in vivo fluorescence imaging. Treatment with @Calmat resulted in a marked reduction in pro-inflammatory cytokines, with levels of IL-6 (1225 ± 67 pg/mL), IL-1β (379 ± 69 pg/mL), and TNF-α (14.1 ± 2 pg/mL), in contrast to the diseased control group (IL-6: 2223 ± 99; IL-1β: 1632 ± 90; TNF-α: 40 ± 3 pg/mL). A similar trend was observed for liver and kidney function biomarkers. Mechanistic studies revealed that @Calmat treatment activates the Bax/Bcl-2 signaling pathway, leading to cell cycle arrest in the G1 phase and subsequent late-phase apoptosis. As a result, the tumor inhibition rate reached 88%, with 80% of treated rats surviving beyond 100 days. These findings highlight the strong potential of @Calmat as a dual-function theranostic agent for the management of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateTriple Negative Breast NeoplasmsChitosanNanoparticlesCalcium CarbonateTheranostic NanomedicineDrug CarriersFluorescent DyesHumansAnimalsCell Line, TumorFemaleRatsApoptosisRats, Sprague-Dawley

Stichwörter der Autor:innen

anticancer efficacyapoptosisbioimagingdrug deliveryfluorescent nanoparticlespharmacokinetics

Substanzen

MethotrexateChitosanCalcium CarbonateDrug CarriersFluorescent Dyes

Autor:innen und Institutionen

  • School of Biomedical Engineering, IIT (BHU), Varanasi 221005, India.
  • Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.
  • Nano 2 Micro Material Design Lab, Department of Chemical Engineering and Technology, IIT (BHU), Varanasi 221005, India.

ORCID-Profile: Manoj Kumar

Zitieren

APA

Verma, R., Zeyaullah, M., Singh, V., Saxena, P. S., Koch, B., & Kumar, M. (2025). Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c02390

Vancouver

Verma R, Zeyaullah M, Singh V, Saxena PS, Koch B, Kumar M. Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.4c02390

BibTeX
@article{Verma2025,
  author = {Verma, Rinki and Zeyaullah, Md and Singh, Virendra and Saxena, Preeti Suman and Koch, Biplob and Kumar, Manoj},
  title = {Chitosan-Functionalized Fluorescent Calcium Carbonate Nanoparticle Loaded with Methotrexate: Future Theranostics for Triple Negative Breast Cancer},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2025},
  doi = {10.1021/acsbiomaterials.4c02390}
}
Kostenlos starten →